Where does Cardurion's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Cardurion's 1 recorded funding rounds.

Premier Alternatives

Cardurion

Biotechnology · Burlington, MA · Founded 2017 · Privately Held (backing)

Developer of cardiovascular therapeutics intended to treat cardiovascular diseases. Cardurion is based in Burlington, MA and was founded in 2017. Its last known valuation is $760 million. It has raised $622 million across 1 recorded round; the latest was a $260 million Series B in Jul 2024.

Last price · $/share

—

Implied valuation

$760.0M

Total raised

$621.8M

Last round

Later Stage VC (Series B)

Jul 2024

Cap table — not yet on record

Cardurion's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Cardurion with a free account

·The complete investor list: 16 names
·Watch Cardurion: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Cardurion

Where does Cardurion's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Cardurion's 1 recorded funding rounds.